JGGDR
DNLI icon

JGP Global Gestao de Recursos’s Denali Therapeutics DNLI Stock Holding History

JGP Global Gestao de Recursos’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-91,760
Closed -$7.2M – 78
2021
Q2 		$7.2M Buy
+91,760
New +$5.68M 2.39% 11

Other funds holding DNLI

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JGP Global Gestao de Recursos's DNLI Position: Q3 2021 in Review

JGP Global Gestao de Recursos sold out of Denali Therapeutics (DNLI) in Q3 2021, closing a stake of 91,760 shares — an estimated $7.2M sold.

JGP Global Gestao de Recursos first reported a position in DNLI in Q2 2021 and held it in 1 quarter. The position peaked at $7.2M in Q2 2021. 214 funds tracked by Wall St. Rank hold DNLI as of Q3 2021.

  • JGP Global Gestao de Recursos reported no remaining Denali Therapeutics position as of Q3 2021 after selling out during the quarter.
  • JGP Global Gestao de Recursos sold 91,760 Denali Therapeutics shares in Q3 2021, an estimated $7.2M.
  • JGP Global Gestao de Recursos first reported a position in Denali Therapeutics in Q2 2021 and held it in 1 quarter.
  • JGP Global Gestao de Recursos's Denali Therapeutics position peaked at $7.2M in Q2 2021.
  • 214 funds tracked by Wall St. Rank held Denali Therapeutics as of Q3 2021.

Based on JGP Global Gestao de Recursos's 13F filing for Q3 2021, filed 4 Nov 2021.